• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的他汀类药物

Statins in Heart Failure.

作者信息

Correale Michele, Abruzzese Silvia, Greco Carmen Adriana, Concilio Morena, Di Biase Matteo, Brunetti Natale Daniele

机构信息

Department of Cardiology, University of Foggia, Viale Pinto 1, 71100 Foggia, Italy.

出版信息

Curr Vasc Pharmacol. 2012 Sep 20.

PMID:23016898
Abstract

Clinical trials demonstrated that statin therapy is associated with a significant reduction in cardiovascular morbidity and mortality when used for either primary or secondary prevention of cardiovascular events. Several studies have shown that statins, having an important effect in the prevention of acute coronary syndromes, are also able to prevent heart failure (HF) in patients with coronary artery disease. This review summarizes the experimental and clinical evidence regarding the role of statins in the management of HF.

摘要

临床试验表明,他汀类药物疗法用于心血管事件的一级或二级预防时,可显著降低心血管发病率和死亡率。多项研究表明,他汀类药物在预防急性冠状动脉综合征方面具有重要作用,还能够预防冠状动脉疾病患者发生心力衰竭(HF)。本综述总结了关于他汀类药物在心力衰竭管理中作用的实验和临床证据。

相似文献

1
Statins in Heart Failure.心力衰竭中的他汀类药物
Curr Vasc Pharmacol. 2012 Sep 20.
2
Pleiotropic effects of statin in therapy in heart failure: a review.他汀类药物在心力衰竭治疗中的多效性作用:综述
Curr Vasc Pharmacol. 2014;12(6):873-84. doi: 10.2174/1570161112999141127161508.
3
Statin use in heart failure: a cause for concern?心力衰竭中使用他汀类药物:值得关注的原因?
Am Heart J. 2006 Jul;152(1):39-49. doi: 10.1016/j.ahj.2005.09.008.
4
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
5
Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis.亲脂性与亲水性他汀类药物治疗心力衰竭:一项调整后间接比较荟萃分析的方案。
Syst Rev. 2013 Apr 23;2:22. doi: 10.1186/2046-4053-2-22.
6
Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.他汀类药物在冠心病和缺血性中风一级及二级预防中的应用。随机试验的荟萃分析。
Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77. doi: 10.5414/cpp41567.
7
Statin therapy in heart failure: for good, for bad, or indifferent?他汀类药物在心力衰竭中的应用:是好是坏还是无关紧要?
Curr Atheroscler Rep. 2014 Jan;16(1):377. doi: 10.1007/s11883-013-0377-x.
8
Primary and secondary prevention of heart failure with statins.他汀类药物用于心力衰竭的一级和二级预防。
Expert Rev Cardiovasc Ther. 2006 Nov;4(6):917-26. doi: 10.1586/14779072.4.6.917.
9
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.增强型体外反搏(EECP):基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
10
Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease - Report From the JASPER Study.他汀类药物对无冠状动脉疾病的射血分数保留心力衰竭患者死亡率的影响——来自 JASPER 研究的报告。
Circ J. 2019 Jan 25;83(2):357-367. doi: 10.1253/circj.CJ-18-0639. Epub 2018 Nov 9.

引用本文的文献

1
Protection against Shiga Toxins.针对志贺毒素的防护
Toxins (Basel). 2017 Feb 3;9(2):44. doi: 10.3390/toxins9020044.
2
Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.他汀类药物对Rab异戊二烯化的抑制作用可诱导细胞糖鞘脂重塑。
Glycobiology. 2016 Feb;26(2):166-80. doi: 10.1093/glycob/cwv084. Epub 2015 Sep 24.
3
Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry.阿托伐他汀治疗与射血分数降低的慢性心力衰竭患者的预后改善相关:Daunia 心力衰竭注册研究结果。
Neth Heart J. 2013 Sep;21(9):408-16. doi: 10.1007/s12471-013-0430-y.